Hippocampal hyperperfusion in Alzheimer's disease
David C Alsop1, Melynda Casement, Cedric de Bazelaire
1Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. dalsop@bidmc.harvard.edu
Neuroimage
|July 8, 2008
Summary
Alzheimer's Disease (AD) brain scans reveal that early atrophy doesn't always mean reduced blood flow. Some affected areas, like the hippocampus, show increased blood flow per tissue volume, suggesting compensatory activity or inflammation.
Area of Science:
- Neurology
- Neuroimaging
- Alzheimer's Disease Research
Background:
- Early Alzheimer's Disease (AD) shows atrophy in brain regions not always reflected by functional imaging deficits.
- This discrepancy between structural changes and functional activity in AD presents a paradox needing investigation.
Purpose of the Study:
- To investigate the relationship between brain atrophy and cerebral blood flow (CBF) in Alzheimer's Disease (AD).
- To explore the functional imaging paradox in early AD using advanced MRI techniques.
Main Methods:
- Utilized volumetric arterial spin labeling (ASL) MRI for blood flow and anatomical imaging in 22 AD patients and 16 controls.
- Compared cerebral blood flow (CBF) and gray matter (GM) maps between groups, analyzing regions with significant mismatches.
Main Results:
- CBF was reduced in the precuneus, parietal, and temporal lobes in AD patients.
- Despite overall GM loss, the hippocampus and medial temporal structures showed elevated atrophy-corrected CBF.
- Significant mismatch between CBF and GM loss was observed in specific brain regions.
Conclusions:
- The hippocampus and other early-affected AD regions exhibit elevated perfusion per unit of gray matter.
- This suggests potential compensatory neural activity, inflammation, or increased vasodilator production in these areas.
- Findings challenge traditional functional imaging interpretations in early AD, highlighting complex pathophysiology.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:19Role of Hippocampus in Memory
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...